Biochem/physiol Actions
A direct dopamine agonist; may be selective for the D3 subtype; no significant affinity for D1 receptors.
Features and Benefits
This compound was developed by Servier. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria: